These Terms & Policies apply generally to World Impact Productions (“WIP”), NLTV Studios, Newline Television, and related production, media, scheduling, uplink, distribution, and special programming partners involved in the development, production, preparation, delivery, and distribution of Public Service Announcement (“PSA”) campaigns.
These Terms & Policies are intended to clarify the standard PSA framework applicable to WIP-led Public Service Announcement campaigns, including but not limited to Breakthroughs, Business with Purpose, Beyond the Beauty, Travel Smart America, Food for Life, Home with Purpose, and other special programming or educational PSA initiatives.
These Terms & Policies supplement and are incorporated by reference into any applicable Production / Media Authorization, proposal, invoice, scheduling document, or related written authorization unless expressly modified in writing by WIP / NLTV Studios.
1. Public Service Announcement Framework
WIP PSA campaigns are public-interest educational media initiatives designed to inform audiences about important issues, innovations, organizations, technologies, solutions, and topics
affecting health, safety, science, medicine, sustainability, families, communities, quality of life, business responsibility, and public awareness.
These campaigns are not traditional commercial advertisements, paid-media buys, direct response advertising campaigns, sponsored commercials, or guaranteed advertising placements.
Featured organizations are selected because their work is relevant to the educational subject being addressed within the PSA. While featured organizations may receive meaningful brand exposure, credibility, visibility, and business benefit through participation, those benefits are a
result of inclusion within an educational PSA campaign, not the purchase of advertising.
2. Selection of Featured Organizations
WIP and its production partners may identify and invite organizations, experts, companies, innovators, nonprofit groups, public-interest leaders, and other participants to appear in or contribute to PSA campaigns.
Selection is based on factors such as:
• relevance to the PSA subject
• public-interest value
• credibility and leadership within the category
• educational importance
• potential audience benefit
• production suitability
• availability of supporting information, visuals, data, experts, or stories
Participation in a PSA campaign is subject to WIP’s discretion and does not create an obligation
for WIP to feature any organization until the applicable Production / Media Authorization is
executed and the campaign moves into active development.
3. Production Model
WIP, directly and through its production, media, scheduling, uplink, and distribution partners, manages the development, scripting, production, editing, compliance preparation, formatting,
delivery, and distribution coordination for PSA campaigns.
A typical PSA campaign may include:
• a :60 PSA version intended for broadcast and digital distribution
• a 3–5 minute educational feature segment
• script development and review
• production and/or asset integration
• post-production editing
• compliance preparation
• closed captioning
• uplink / delivery preparation
• digital and targeted media distribution support
• distribution reporting after the applicable distribution window
The exact structure, length, style, creative direction, and deliverables may vary based on the campaign, subject matter, available assets, review requirements, production needs, and distribution standards.
4. Educational Purpose
The purpose of WIP PSA campaigns is to educate, inform, and raise awareness around meaningful subjects of public interest.
The PSA format is intended to present important information in a credible, documentary-style, educational manner. The PSA may identify and highlight a featured organization, but the primary editorial purpose remains public education and awareness rather than overt promotion.
WIP reserves the right to structure, edit, and position each PSA in a manner consistent with public-interest standards, broadcast suitability, editorial integrity, and distribution partner expectations.
5. Review and Approval Process
Featured organizations will generally have the opportunity to review and approve the Review Script before production proceeds.
Featured organizations will also generally have the opportunity to review the Review Edit before finalization and distribution for purposes of factual accuracy, messaging alignment, brand
comfort, claims sensitivity, and regulatory review where applicable.
Requested revisions should be reasonable, timely, and related to accuracy, compliance, claims, brand usage, or material messaging concerns.
WIP will make commercially reasonable efforts to incorporate approved revisions while preserving the integrity of the PSA format, editorial standards, production quality, and
distribution requirements.
Final editorial responsibility remains with WIP to ensure that the PSA remains suitable for public-interest distribution and consistent with broadcast, legal, production, and PSA standards.
6. Medical, Legal, Regulatory, and Compliance Review
For healthcare, medical device, pharmaceutical, biotechnology, scientific, food, wellness, financial, legal, safety, or otherwise regulated organizations or topics, the featured organization is responsible for reviewing and approving any claims, statements, product references, clinical descriptions, scientific assertions, regulatory language, statistics, indications, outcomes, comparisons, or other sensitive content related to its organization, products, services, technologies, or field of work.
WIP is not acting as the featured organization’s legal, medical, regulatory, FDA, FTC, claims- substantiation, clinical, financial, tax, or compliance advisor.
Featured organizations are responsible for identifying any necessary limitations, disclaimers, approvals, substantiation requirements, prohibited claims, or regulatory sensitivities during the review process.
WIP will accommodate reasonable internal review cycles where appropriate, but featured organizations are expected to provide feedback within agreed timelines so production and distribution schedules are not unnecessarily delayed.
7. Participant Materials, Releases, and Permissions
Featured organizations may provide WIP with logos, footage, photographs, product visuals, facility visuals, interviews, testimonials, data, research, documents, case studies, graphics,
animations, audio, social media content, or other materials for potential use in the PSA.
By providing materials, the featured organization represents that it has the necessary rights, permissions, consents, releases, licenses, and approvals for WIP to use those materials in connection with the PSA campaign.
This includes, where applicable:
• employee releases
• patient / customer releases
• HIPAA or privacy authorizations
• location releases
• third-party footage or image licenses
• music or media rights
• trademark permissions
• institutional approvals
• clinical or regulatory approvals
WIP may request written confirmation of such permissions where appropriate.
8. Optional Filming and Field Production
Some PSA campaigns can be produced using existing footage, approved assets, interviews, animation, stock footage, remote interviews, studio narration, and other available materials.
Where on-location filming, field production, special interviews, facility footage, patient/customer stories, product demonstrations, or custom production services are recommended or requested, WIP may scope such production separately.
Optional field production may involve additional fees unless otherwise included in the applicable Production / Media Authorization.
WIP may recommend avoiding unnecessary field production where existing assets are sufficient or where a more efficient remote, studio, stock, or hybrid production approach better serves the PSA.
9. Administrative Fee Structure
WIP PSA campaigns are supported through a grant-supported, philanthropic, contributed- services, and partner-supported framework.
The featured organization is generally responsible only for a small fraction of the costs: the administrative, scheduling, compliance, captioning, uplink, delivery, and distribution-support components that are not covered by the grant-supported or contributed-services structure.
Although there is a track record of many years testifying to the expansive distribution and broadcast of these PSA’s the administrative fee is not payment for guaranteed advertising
airtime, guaranteed impressions, guaranteed sales, commercial media placement, or sponsorship of a commercial advertisement.
The administrative fee supports items such as:
• scheduling coordination
• production coordination
• compliance preparation
• closed captioning
• technical formatting
• uplink / delivery coordination
• distribution administration
• campaign administration
• partner coordination
10. Payment, Invoicing, and Non-Refundability
Unless otherwise stated in writing, invoices are issued according to the schedule set forth in the applicable Production / Media Authorization.
An initial invoice is typically triggered upon execution of the Production / Media Authorization because WIP, NLTV Studios, and related partners begin allocating scheduling, compliance,
production, uplink, delivery, and distribution resources once the project is activated.
Fees are generally non-refundable once invoiced and/or once scheduling, pre-production, production, compliance, captioning, coordination, uplink preparation, or distribution preparation has begun.
The featured organization’s script and review-edit approval rights are intended to protect accuracy, compliance, and brand comfort, but those rights do not convert the administrative fee into a refundable media-buy payment.
Payment terms, deferred payment schedules, deposits, installment structures, or other billing arrangements may be adjusted only if agreed in writing.
11. Distribution Framework
PSA distribution is materially different from commercial advertising distribution.
PSAs are submitted, delivered, distributed, reviewed, accepted, scheduled, and aired through public-interest, network, affiliate, station, digital, syndication, media-partner, and/or platform-
specific processes.
Placement decisions may depend on:
• public-interest relevance
• subject matter
• available PSA inventory
• programming needs
• audience alignment
• local station discretion
• affiliate discretion
• network review
• technical requirements
• timing windows
• editorial suitability
• compliance standards
• platform policies
References to national networks, international networks, local markets, digital platforms, newsbreak environments, out-of-home platforms, or targeted media channels describe the distribution framework, intended submission categories, and types of environments for which a PSA may be prepared and submitted.
Because all PSA placements are ultimately the final decision of the networks themselves, such references cannot formally “guarantee” specific networks, stations, particularly in terms of
programs, air dates, time slots, number of airings, audience levels, impressions, GRPs, or total reach. However, typical results are shown in our Case Study examples.
12. Paid, Earned, Bartered, Partner-Supported, and PSA Discretionary Placement
WIP PSA campaigns may involve a combination of public-interest PSA submission, broadcast distribution systems, media partner distribution, digital placement, targeted online distribution,
PR/media support, affiliate review, contributed services, platform-based placement, and discretionary PSA inventory.
These campaigns should not be interpreted as conventional paid advertising buys unless expressly identified as such in writing.
Because PSA distribution is not purchased and scheduled in the same way as commercial advertising, the appropriate measurement standard is post-campaign reporting, not pre-scheduled commercial spot affidavits or guaranteed paid-media schedules.
13. Obligations:
WIP’s obligation is to produce, prepare, submit, deliver, uplink, distribute, and/or coordinate the PSA through the applicable PSA framework described in the Production / Media Authorization.
PSA particulars in terms of final airing, acceptance, timing, and frequency remain subject to third-party distribution environments and public-interest inventory decisions which ultimately we do not control. However, the networks listed in the Production Media Authorization are listed because they continue to consistently run these PSA’s, in volume.
14. Reporting and Distribution Reports
PSA reporting is typically compiled after distribution has had sufficient time to mature across broadcast, local, digital, affiliate, platform, and partner environments.
Because PSAs may be distributed across multiple independent systems, there is generally no single centralized live dashboard or unified real-time reporting mechanism.
Different networks, stations, affiliates, distributors, and platforms operate on different reporting cycles and may provide varying levels of confirmation.
At the conclusion of the applicable distribution window, WIP may provide a consolidated Distribution Report where available and applicable. Such report may include:
• networks, stations, platforms, or distribution environments where the PSA was placed or reported
• number of airings or placements where reported
• station, network, or platform confirmations where available
• digital distribution activity where available
• estimated audience reach or impression ranges
• media type breakdown
• overall campaign summary and reach context
Distribution Reports are based on available third-party, partner, platform, affiliate, station, network, distributor, and industry reporting sources.
WIP does not guarantee that every network, affiliate, station, or platform will provide full affidavits, exact air times, logs, confirmations, or uniform reporting detail. But again, the history has always shown expansive and frequent coverage.
15. Media Value, Reach, and Impression Estimates
Any media value, production value, reach estimate, impression estimate, comparable valuation, audience projection, or distribution value provided by WIP is an estimate only.
Such estimates may reflect the approximate commercial value of production, writing, producing, editing, narration, compliance preparation, closed captioning, uplink/delivery, PR/media support, distribution infrastructure, digital placement, broadcast/digital exposure, and related campaign services if similar elements were procured commercially.
Media-value estimates are not guaranteed paid-media spend, guaranteed airtime, guaranteed impressions, guaranteed reach, guaranteed GRPs, guaranteed sales, or guaranteed business
outcomes.
Actual reach and exposure may vary based on distribution acceptance, timing, topic relevance, public-interest value, available inventory, station activity, platform reporting, digital engagement, and other factors outside WIP’s direct control.
16. Talent, Hosts, Narrators, and Celebrity Participation
Certain WIP PSA campaigns include A-list, nationally recognized, or otherwise notable host, narrator, voiceover, or on-camera talent participation.
Talent participation is formally finalized within the production framework based on subject matter, timing, availability, approval, suitability, scheduling, production needs, and compliance considerations.
Any host, narrator, celebrity, or talent appearing in or narrating a PSA participates in the context of public-interest storytelling.
Such participation does not constitute a commercial endorsement of the featured organization, its products, services, technologies, claims, or business operations unless expressly agreed in a separate written endorsement agreement.
Featured organizations may not use talent names, voices, images, likenesses, clips, or references outside the approved PSA context in any way that implies a direct product endorsement, commercial sponsorship, paid testimonial, or independent celebrity endorsement.
17. Ownership
Unless expressly stated otherwise in writing, WIP retains ownership of the PSA content, editorial structure, scripts, production materials, project files, master files, distribution versions, creative work product, and associated intellectual property developed by WIP or its partners.
The featured organization retains ownership of its pre-existing trademarks, logos, approved footage, product assets, proprietary materials, and materials supplied to WIP.
The featured organization grants WIP the right to use approved company names, logos, trademarks, footage, materials, interviews, and related assets in connection with development,
production, editing, promotion, distribution, reporting, archiving, and reasonable referencing of the PSA campaign.
18. Usage Rights Granted to Featured Organizations
Upon completion and delivery of final PSA assets, the featured organization will generally receive a Master Digital Copy of the applicable PSA asset and a non-exclusive, perpetual, royalty-free license to use the completed PSA content for approved educational, informational, PR, website, social media, internal communications, investor communications, presentation,
recruiting, stakeholder, and related non-commercial informational purposes.
Such usage must remain consistent with the educational, public-interest nature of the PSA campaign.
The featured organization may create reasonable excerpts, clips, or derivative versions for approved communications purposes, provided such usage does not:
• materially alter the meaning of the PSA
• remove required context
• imply unsupported claims
• imply direct endorsement by talent
• imply endorsement by networks or distribution partners
• convert the PSA into a standalone commercial advertisement outside the PSA framework
• use talent in a way that suggests product endorsement
• misrepresent the PSA’s purpose, distribution, or editorial nature
Any usage beyond the PSA/public-interest framework may require separate written approval.
19. Use of Featured Organization Name and Logo
WIP may use the featured organization’s name, logo, and approved identifiers in connection with the PSA campaign, including within the PSA, end frames, lower thirds, distribution materials,
press materials, campaign summaries, internal reporting, external references, and related campaign materials.
Such use will be limited to the PSA campaign and related public-interest materials and will not be used to imply that the featured organization endorses WIP, NLTV Studios, Newline, any vendor, partner, network, platform, or unrelated product or service.
Where a featured organization has specific brand guidelines or logo approval requirements, those should be provided to WIP in advance.
20. Press Releases, Social Media, and Public Announcements
All press releases, public announcements, social media posts, external messaging, or public references related to a WIP PSA campaign should be reviewed and approved in advance by WIP’s Media Department or designated agency representative.
This policy is intended to protect:
• the PSA format
• public-interest positioning
• broadcast relationships
• host/narrator considerations
• talent restrictions
• network and distributor sensitivities
• featured organization brand integrity
• regulatory and claims accuracy
• consistency of public messaging
Featured organizations should not issue public announcements suggesting guaranteed network placement, commercial endorsement, celebrity endorsement, or paid advertising unless such language has been approved by WIP in writing.
WIP may provide approved summary language for website, press, and social use.
21. No Endorsement by Networks, Talent, or Partners
Distribution, airing, carriage, acceptance, availability, narration, hosting, or participation in a PSA does not constitute an endorsement of the featured organization, its products, services,
technologies, clinical claims, business operations, or commercial offerings by any network, station, affiliate, digital platform, host, narrator, celebrity, production partner, media partner, distributor, or vendor.
Similarly, inclusion in a WIP PSA does not imply endorsement of WIP or its partners by the featured organization beyond participation in the PSA campaign itself.
22. Confidentiality
WIP will use reasonable care to protect non-public, confidential, or proprietary information clearly identified by a featured organization as confidential and provided solely for PSA
development.
Confidentiality obligations do not restrict WIP from producing, distributing, referencing, reporting on, or archiving approved PSA campaign materials.
Confidentiality does not apply to information that is publicly available, independently developed, already known, approved for use, disclosed without restriction, or required to be disclosed by law.
23. Client References, Case Studies, and Prior Campaign Materials
WIP may provide curated prior PSA examples, representative case studies, sample formats, public-facing work, and sample reporting structures where appropriate.
Due to confidentiality, legal, PR, regulatory, and client-sensitivity considerations, WIP does not automatically provide direct contact information for prior participants, participant fee details, raw client distribution reports, unredacted affidavits, proprietary distribution logs, or confidential campaign data from other campaigns.
24. No Guarantee of Business Results
WIP makes no guarantee of sales, leads, revenue, investment, donations, market share, regulatory approval, clinical adoption, customer acquisition, web traffic, media inquiries,
physician adoption, patient demand, investor interest, reimbursement, fundraising, partnership activity, or other business outcomes.
A PSA may provide substantial educational, reputational, awareness, credibility, PR, positioning, and brand value, but all business outcomes depend on numerous factors outside WIP’s control.
25. Limitation of Liability
To the fullest extent permitted by law, WIP, NLTV Studios, Newline, and their respective officers, directors, employees, contractors, affiliates, representatives, production partners, media partners, distribution partners, vendors, and service providers shall not be liable for indirect, incidental, consequential, special, punitive, reputational, lost-profit, lost-opportunity, lost-revenue, lost-business, business-interruption, or similar damages arising from or relating to any PSA campaign.
This includes, without limitation, claims related to:
• distribution timing
• non-placement by a particular network or station
• limited reporting availability
• network or affiliate decisions
• platform decisions
• talent availability
• editorial decisions
• campaign reception
• estimated reach
• media value
• business expectations
• public response
• delays outside WIP’s control
Except in cases of proven willful misconduct or gross negligence, any aggregate liability of WIP / NLTV Studios related to a PSA campaign shall not exceed the administrative fees actually paid
by the featured organization under the applicable Production / Media Authorization.
26. Indemnification
The featured organization agrees to indemnify and hold harmless WIP, NLTV Studios, Newline, and their respective officers, directors, employees, contractors, partners, vendors, affiliates, and representatives from claims, damages, liabilities, costs, losses, or expenses arising from or related to:
• materials, footage, data, claims, logos, trademarks, or information supplied by the featured organization
• inaccurate, misleading, non-compliant, or unsubstantiated claims supplied or approved by the featured organization
• failure to obtain required permissions, releases, consents, licenses, or regulatory approvals
• unauthorized use of third-party materials supplied by the featured organization
• misuse or out-of-context use of PSA assets by the featured organization after delivery
• claims arising from the featured organization’s products, services, technologies, operations, regulatory status, or business activities
• violation of law, regulation, privacy rights, publicity rights, intellectual property rights, or contractual obligations by the featured organization
27. Force Majeure and Third-Party Decisions
WIP shall not be responsible for delays, rescheduling, non-placement, reporting limitations, distribution adjustments, production interruptions, or performance limitations caused by events or decisions outside WIP’s reasonable control.
Such circumstances may include:
• network decisions
• affiliate decisions
• platform policies
• distributor limitations
• talent availability
• technical failures
• outages
• strikes
• labor disputes
• public emergencies
• acts of God
• severe weather
• war
• terrorism
• civil unrest
• government action
• legal or regulatory restrictions
• pandemics
• supply-chain interruptions
• third-party delays
• force majeure events
28. Updates to Terms & Policies
WIP may update these Terms & Policies from time to time to reflect changes in production processes, distribution practices, compliance requirements, partner standards, reporting
procedures, or operational needs.
29. Acceptance of Terms
By executing a Production / Media Authorization, approving PSA participation, providing materials, participating in production, accepting delivery of PSA assets, or authorizing work to proceed, the featured organization acknowledges the PSA framework and agrees to the applicable Production & Media Terms and Policies, except to the extent expressly modified in writing by WIP / NLTV Studios.